Implementing new guidelines would increase screening eligibility and detection of diabetes and prediabetes, according to an analysis published in JAMA.
Screening, prevention and treatment of diabetes in younger patients is “suboptimal” in the United States, the authors of the analysis wrote. To facilitate earlier detection and treatment, the U.S. Preventive Services Task Force and American Diabetes Association (ADA) recently lowered the recommended age to start diabetes screening to 35 years.
“The new guidelines partially address the front end of this chain [of diabetes